Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/27/20 → 4/27/23 |
Funding
- DP Clinical, Inc. (Prot #MT-3921-G01)
- Mitsubishi Tanabe Pharma America, Inc. (Prot #MT-3921-G01)
Prot #MT-3921-G01: A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single Ascending Dose of MT-3921 in Subjects with Acute Spinal Cord Injury
- Ganju, Aruna (PD/PI)
Project: Research project